Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NETWORK × Disease × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 1/2 1

Status

Sponsor Class

OTHER 7 INDUSTRY 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Central Nervous System Neoplasms 8 Lung Neoplasms 6 Leukemia, Myeloid, Acute 6 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Multiple Myeloma 4 Leukemia 4 Gliosarcoma 4 Glioblastoma 4 Burkitt Lymphoma 4 Squamous Cell Carcinoma of Head and Neck 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Congenital Abnormalities 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Radiation Injuries 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Oligodendroglioma 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2

Interventions

carfilzomib 1 Dexamethasone 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02204241 2023-07-03

CCD

European Myeloma Network B.V.

Phase 1/2 Completed

Disease, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡